How to Compare GLP-1 Costs and Access

A monthly price is not the full cost

Two offers can look similar but cover different products, doses, supply lengths, visits, or services. One may be an insured copay and another may be a cash price. One may cover an FDA-approved brand and another may cover a compounded product. Compare the same item and the full recurring cost.

Terms can change: Coverage and manufacturer terms in this article were checked against official pages on August 26, 2026. Recheck every term on the day you enroll, pay, refill, or publish a price. A dated price is not a guarantee. Medicare NovoCare Lilly

Step 1: Identify exactly what is being sold

• Brand and active ingredient
• FDA-approved brand or compounded product
• Injection or tablet
• Strength and concentration
• Number of doses or tablets
• 28-day or 30-day supply
• Single-dose or multi-dose container
• Pharmacy and delivery route

Wegovy and Zepbound are FDA-approved branded products for label-defined uses. Compounded semaglutide and tirzepatide are not FDA approved, and FDA does not review compounded drugs before sale for safety, effectiveness, or quality. FDA Wegovy label FDA Zepbound label FDA

Do not accept labels such as "generic Wegovy" or "same as Zepbound" without an FDA source for the exact product. The evidence used for this guide did not verify an approved generic for either brand.

Step 2: Build a total monthly cost

Put each option into the same worksheet. Use the amount you would actually pay, not a starting price in a large headline.

• Medication after deductible, copay, coinsurance, coupon, or cash offer
• Membership or subscription fee
• Initial and follow-up visit fees
• Laboratory or monitoring fees required for your care
• Needles, syringes, and sharps disposal
• Shipping, refrigeration, and missed-delivery charges
• Time and travel for visits or pharmacy pickup
• Price after the introductory period
• Refill deadline, annual cap, and offer expiration

Some fields will be zero for one route and meaningful for another. If a seller will not provide a clear total, record the item as unknown instead of assuming it is included.

Step 3: Understand the insurance route

Call the number on your insurance card or use the plan portal. Ask about the exact product, formulation, dose, and medical indication. A formulary listing does not always mean immediate coverage.

• Is the product on the formulary?
• Is prior authorization required?
• Is step therapy required?
• Is there a quantity limit?
• Does the plan require a specific diagnosis or BMI record?
• Which pharmacy network must be used?
• What are the deductible, copay, and coinsurance?
• When can the rule or formulary change?
• How do I request an exception or appeal a denial?

For Medicare Part D, CMS says an enrollee, prescriber, or representative can request a formulary or tiering exception. A formulary exception may ask to waive prior authorization, step therapy, or quantity limits when the prescriber provides the required medical-necessity support. CMS

Medicare information checked August 26, 2026

Medicare's official page said the temporary GLP-1 Bridge began July 1, 2026 for eligible adults with Part D. It listed Foundayo tablets, Wegovy injection or tablets, and Zepbound KwikPen. It did not include Zepbound single-dose vials or single-dose pens in the Bridge. Medicare

As checked August 26, 2026, eligible Part D beneficiaries pay $50 per month through December 31, 2027. Medicare says this payment does not count toward the Part D deductible or out-of-pocket limit, cannot be reduced by Extra Help, and cannot use the Medicare Prescription Payment Plan. Eligibility, prior authorization, product, formulation, and pharmacy processing must still be verified. Medicare

The Bridge page lists adults age 18 or older who meet one of these eligibility paths: BMI of at least 35; BMI of at least 30 with heart failure with preserved ejection fraction, uncontrolled hypertension, or stage 3a or higher chronic kidney disease; or BMI of at least 27 with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. These are Bridge program rules, not a complete statement of when a medicine is clinically appropriate. A prescription is required, and the prescriber must certify use with a reduced-calorie diet and increased physical activity. Medicare

Verify Medicare before relying on this section: The Bridge is temporary, and coverage rules can change. Confirm eligibility, product, formulation, prior authorization, pharmacy processing, and out-of-pocket cost with Medicare and the Part D plan on the day of use.

Step 4: Separate savings cards from self-pay

A savings card usually reduces a price under stated eligibility rules. Self-pay means paying a cash amount without using insurance for that purchase. The same manufacturer may have more than one route, and the rules can differ by product, formulation, dose, insurance status, and pharmacy.

As checked August 26, 2026, NovoCare listed cash routes and a separate savings offer for Wegovy. The page stated that eligibility and restrictions apply and that the program can be changed or canceled. It also said all Wegovy doses require a prescription. NovoCare

Lilly announced on March 16, 2026 that Zepbound KwikPen self-pay access was available through LillyDirect and major pharmacies, starting with the 2.5 mg dose. The announcement said adults need a valid on-label prescription and that the KwikPen card does not apply to single-dose vials or the single-dose pen. It did not confirm current prices for every higher dose in the fetched material. Lilly

Because manufacturer terms move quickly, this guide favors verification steps over a price table. Ask for the exact price for your dose today, the price after any starter period, the number of allowed fills, the expiration date, and whether insurance claims or government coverage change eligibility.

Step 5: Understand the warning about compounded products

Compounded semaglutide and tirzepatide are not FDA approved. This guide does not list or price compounded products. FDA says compounded drugs should be used only when a patient's medical need cannot be met by an FDA-approved drug. FDA

FDA also warns that some compounded semaglutide products use salt forms, such as semaglutide sodium or acetate, that are different active ingredients from the base form used in approved products. FDA says it lacks information showing the same chemical and pharmacologic properties and is unaware of a lawful basis for using those salts in compounding. FDA

FDA has reported serious compounded-semaglutide dosing errors caused by varying concentrations and confusion among milligrams, milliliters, and "units." Some patients received five to 20 times the intended dose. FDA dosing alert

If a compounded medicine is prescribed because an FDA-approved option cannot meet a specific medical need, ask the prescriber or pharmacist to explain the prescribed dose and how to measure it using the supplied device. Never treat a low price as proof of FDA approval.

Step 6: Compare one year, not one month

Create three 12-month scenarios: insurance approval, insurance denial, and offer expiration. Add every recurring fee. If treatment may change dose or formulation, ask whether the price changes. This does not predict how long you will use treatment, but it reveals whether a route is financially fragile.

Final verification checklist

• I know the exact product, formulation, dose, quantity, and pharmacy.
• I know whether the product itself is FDA approved or compounded.
• I have the full monthly cost, not only the medicine headline price.
• I know the price after a starter offer and the offer expiration.
• I confirmed insurance rules for this indication and formulation.
• I know who submits prior authorization and exceptions.
• I checked prescription, storage, shipping, and support terms.
• I saved the official terms and date checked.

Bottom line

The best access option is not always the lowest advertised number. Compare the exact product, full recurring cost, coverage work, safety controls, and long-term stability. Recheck official terms before every important decision.